Table 1 Patients’ characteristics

Male/female, n (male%)

43/20 (68.3%)

Total protein (g/dL)

6.50 [6.05–7.20]

Age (y/o)

46.0 [41.0–54.0]

Hematocrit (%)

38.5 [30.8–44.5]

Systolic BP (mmHg)

221 [201–236]

Platelet count (x10⁴/mm³)

22.0 [15.2–25.0]

Diastolic BP (mmHg)

140 [127–155]

LDH (U/L)

330 [251–455]

Heart rate (beats/min)

105 [92–115]

Serum potassium (mEq/L)

3.70 [3.30–4.20]

Body mass index (kg/m²)

28.2 [24.1–31.0]

LDL-cholesterol (mg/dL)

118 [101–147]

Diabetes, n (%)

9 (14.3%)

HDL-cholesterol (mg/dL)

43 [36–52]

Smoking, n (%)

34 (54.0%)

Hemoglobin A1c (%)

5.5 [5.0–6.0]

Aware of hypertension, n (%)

50 (79.4%)

eGFR (mL/min/1.73 m²)

30.0 [11.7–51.3]

Treatment (-)

39 [78.0%]

Urine protein (g/gCr)

2.76 [0.62–4.53]

Treatment (+)

11 [22.0%]

PRA (ng/mL/hr)

12.5 [4.5–27.0]

Duration of hypertension (y)

4.0 [1.5–10.0]

Plasma aldosterone (pg/mL)

208 [133–371]

BNP (pg/mL)

618 [289–1494]